Acurx Pharmaceuticals is a biotechnology business based in the US. Acurx Pharmaceuticals shares (ACXP) are listed on the NASDAQ and all prices are listed in US Dollars. Acurx Pharmaceuticals employs 4 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Acurx Pharmaceuticals stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – ACXP. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Acurx Pharmaceuticals stock price (NASDAQ: ACXP)
Use our graph to track the performance of ACXP stocks over time.Acurx Pharmaceuticals shares at a glance
Latest market close | $3.56 |
---|---|
52-week range | $2.33 - $4.85 |
50-day moving average | $3.70 |
200-day moving average | $3.52 |
Wall St. target price | $13.33 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.49 |
Buy Acurx Pharmaceuticals stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Acurx Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Acurx Pharmaceuticals price performance over time
Historical closes compared with the close of $3.56 from 2023-02-01
1 week (2023-01-26) | -6.32% |
---|---|
1 month (2022-12-30) | -10.55% |
3 months (2022-11-02) | 29.45% |
6 months (2022-08-02) | -6.07% |
1 year (2022-02-02) | -12.75% |
---|---|
2 years (2021-01-29) | N/A |
3 years (2020-01-29) | N/A |
5 years (2018-01-29) | N/A |
Acurx Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -55.23% |
Return on equity TTM | -95.34% |
Profit margin | 0% |
Book value | $0.84 |
Market capitalisation | $46.1 million |
TTM: trailing 12 months
Acurx Pharmaceuticals share dividends
We're not expecting Acurx Pharmaceuticals to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (3.77% forward annual dividend yield)
- Novartis AG ADR (NVS.US) (3.71% forward annual dividend yield)
- Merck-and-Company (MRK.US) (2.75% forward annual dividend yield)
Acurx Pharmaceuticals overview
Acurx Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase IIa clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is based in Staten Island, New York. .
Acurx Pharmaceuticals in the news
Presenting on the Emerging Growth Conference on January 25 Register Now
Presenting on the Emerging Growth Conference on January 25 Register Now
Frequently asked questions
What percentage of Acurx Pharmaceuticals is owned by insiders or institutions?Currently 21.181% of Acurx Pharmaceuticals shares are held by insiders and 13.203% by institutions. How many people work for Acurx Pharmaceuticals?
Latest data suggests 4 work at Acurx Pharmaceuticals. When does the fiscal year end for Acurx Pharmaceuticals?
Acurx Pharmaceuticals's fiscal year ends in December. Where is Acurx Pharmaceuticals based?
Acurx Pharmaceuticals's address is: 259 Liberty Avenue, Staten Island, NY, United States, 10305 What is Acurx Pharmaceuticals's ISIN number?
Acurx Pharmaceuticals's international securities identification number is: US00510M1045
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert